Towards a gene therapy for age-related macular degeneration (AMD)

Project Information

Opti-AAV

Grant agreement ID: 101069382

DOI

10.3030/101069382

Project closed

EC signature date 31 May 2022

Start date 1 July 2022

End date 31 December 2023

Funded under

• European Research Council (ERC)

Total cost

No data

EU contribution

€ 150 000,00

Coordinated by

THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLIN
Ireland

CORDIS provides links to public deliverables and publications of HORIZON projects.

Links to deliverables and publications from FP7 projects, as well as links to some specific result types such as dataset and software, are dynamically retrieved from OpenAIRE .

Publications

Peer reviewed articles (3)

Matrix metalloproteinase-3 (MMP-3)-mediated gene therapy for glaucoma

Author(s): O'Callaghan J, Delaney C, O'Connor M, van Batenburg-Sherwood J, Schicht M, Lütjen-Drecoll E, Hudson N, Ni Dhubhghaill S, Humphries P, Stanley C, Keravala A, Chalberg T, Lawrence MS, Campbell M.
Published in: Science Advances, Issue 9, 2023, ISSN 2375-2548
Publisher: Science Advances
DOI: 10.1126/SCIADV.ADF6537

Immunohistochemical Analysis of Tight Junction Proteins.

Author(s): Greene C, Campbell M.
Published in: Methods in Molecular Biology, 2022, ISSN 1940-6029
Publisher: Methods in Molecular Biology
DOI: 10.1007/978-1-0716-2289-6_18

The CLDN5 gene at the blood-brain barrier in health and disease

Author(s): Hashimoto Y, Greene C, Munnich A, Campbell M.
Published in: Fluids and Barriers of the CNS, 2023, ISSN 2045-8118
Publisher: Fluids and Barriers of the CNS
DOI: 10.1186/s12987-023-00424-5